Reporting pharmacoeconomic evaluations C. I. CarswellJ. A. Paladino Editorial 17 September 2012 Pages: 1073 - 1073
Economic evaluations of healthcare programmes and decision making Marieke E. van VeldenJohan L. SeverensAnnoesjka Novak Review Article 17 September 2012 Pages: 1075 - 1082
Antiviral agents for influenza Larry D. LyndRon GoereeBernie J. O’Brien Review Article 17 September 2012 Pages: 1083 - 1106
Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US Ralph P. InsingaErik J. DasbachElamin H. Elbasha Review Article 17 September 2012 Pages: 1107 - 1122
Acute pyelonephritis among adults Patricia BrownMoran KiBetsy Foxman Review Article 17 September 2012 Pages: 1123 - 1142
Eliciting social preference weights for Functional Assessment of Cancer Therapy-Lung health states Paul KindSusan Macran Original Research Article 17 September 2012 Pages: 1143 - 1153
Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancer Niels NeymarkPilar LianesJan P. van Meerbeeck Original Research Article 17 September 2012 Pages: 1155 - 1166
The importance of drug adverse effects compared with seizure control for people with epilepsy Andrew LloydEmma McIntoshMartin Price Original Research Article 17 September 2012 Pages: 1167 - 1181